ISSN: 2167-7719

空気および水に媒介される病気

オープンアクセス

当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

インデックス付き
  • 索引コペルニクス
  • Google スカラー
  • シェルパ・ロミオ
  • Jゲートを開く
  • Genamics JournalSeek
  • アカデミックキー
  • ウルリッヒの定期刊行物ディレクトリ
  • レフシーク
  • ハムダード大学
  • エブスコ アリゾナ州
  • OCLC-WorldCat
  • ジュネーブ医学教育研究財団
  • ICMJE
このページをシェアする

抽象的な

Macrophage Models for Tuberculosis Studies

Wei T, Li F, Huang Q, Bao F and Liu A

Setting: Macrophage models create an environment for the growth of Mycobacterium tuberculosis and can be applied to studies on the intracellular pathogen. Objective: To review macrophage models for tuberculosis studies in terms of the cell sources and applications. Methods: The online English database PubMed, Chinese databases such as CNKI, SinoMed, and Wanfang were searched up to December 2010 for published articles. Two groups of terms were used for the information retrieval, one of which includes macrophage model, macrophages model, macrophage models, macrophages models, macrophage, and macrophages; the other group of terms comprises Mycobacterium tuberculosis. For PubMed, the two groups of English terms were applied, while for the Chinese databases, related Chinese terms were used. Results: Cell sources of macrophage models include murine bone marrows, human peripheral blood, human lungs, and cell lines. The screened antituberculosis drugs are Western drugs such as ciprofloxacin and ofloxacin, and traditional Chinese medications like pittosporum brevicalyx (oliv.) gagnep and ranunculus ternatus thunb. The regulation of SigB and SigF was described in the pathogenesis of tuberculosis, while pknE mutant modifying the innate immune response in immuno-mechanism of tuberculosis. Conclusions:There are four major cell sources for developing a macrophage model, which can be applied to studies on screening both Western and Chinese anti-TB drugs, figuring out the pathogenesis and immunemechanism of TB with some key issues remaining to be dealt with.